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a Healthy Life Calculator for Older Adults 
 
Abstract 
Introduction 
 Planning for the future would be easier if we knew how long we will live and, more 
importantly, how many years we will be healthy and able to enjoy it.   There are few well-
documented aids for predicting our future health.  We attempted to meet this need for persons 65 
years of age and older.   
Methods  
Data came from the Cardiovascular Health Study, a large longitudinal study of older 
adults that began in 1990.  Years of life (YOL) were defined by measuring time to death.  Years 
of healthy life (YHL) were defined by an annual question about self-rated health, and years of 
able life (YABL) by questions about activities of daily living. Years of healthy and able life 
(YHABL) were the number of years the person was both Healthy and Able. We created 
prediction equations for YOL, YHL, YABL, and YHABL based on the demographic and health 
characteristics that best predicted outcomes.  Internal and external validity were assessed.   The 
resulting CHS Healthy Life Calculator (CHSHLC) was created and underwent three waves of 
beta testing.   
Findings   
A regression equation based on 11 variables accounted for about 40% of the variability 
for each outcome.  Internal validity was excellent, and external validity was satisfactory.   As an 
example, a very healthy 70-year-old woman might expect an additional 20 YOL, 16.8 YHL, 16.5 
YABL, and 14.2 YHABL.  The CHSHLC also provides the percent in the sample who differed 
by more than 5 years from the estimate, to remind the user of variability. 
Discussion 
 The CHSHLC is currently the only available calculator for YHL, YABL, and YHABL.  
It may have limitations if today’s users have better prospects for health than persons in 1990.  
But the external validity results were encouraging.  The remaining variability is substantial, but 
this is one of the few calculators that describes the possible accuracy of the estimates. 
Conclusion 
 The CHSHLC, currently at http://diehr.com/paula/healthspan, meets the need for a 
straightforward and well-documented estimate of future years of healthy and able life that older 
adults can use in planning for the future. 
http://biostats.bepress.com/uwbiostat/paper407
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1.0 Introduction 
 Older adults often need to make decisions about the future, including possible relocation 
from their current home.  Those who expect a long and healthy life may plan for an active 
retirement and consider moving to a resort community.  Those with worse prospects may choose 
instead to move near their children or to a retirement community with assisted care.  It would 
help to have an estimate of how many healthy and active years older adults could anticipate, but 
there are no documented tools for doing so.   
United States life tables (such as from the Social Security Administration 1 ) show the 
expected number of additional years of life, based on a person’s age and sex, but they do not 
incorporate health characteristics.   There are no well-documented tools for estimating a person’s 
future years of healthy life, or years in which they will be able to perform basic activities of daily 
living (ADL).   
 Our goal was to develop useful and accessible estimates of total years of life, years of 
healthy life and years of life free of ADL difficulty, based on data from the Cardiovascular 
Health Study (CHS), a large longitudinal study of persons aged 65-99 at baseline.  This 
manuscript describes the process of creating and evaluating the CHS Healthy Life Calculator 
(CHSHLC).  Additional detail is available in the detailed methods appendices, described below. 
 
2.0 Methods 
2.1 Data 
Description of CHS 
 The Cardiovascular Health Study (CHS), funded by the National Heart and Lung Blood 
Institute, recruited 5201 older adults in 1990 from Medicare eligibility lists in four U.S. 
communities. Persons who used wheelchairs at home, were under treatment for cancer, or were 
not expected to participate for 3 years after baseline were ineligible.  More details about the 
study design can be found elsewhere. 2 CHS followed enrollees’ health from baseline in 1990 to 
the analysis date (2013), providing 23 years of follow-up.  A second cohort of 687 African 
Americans began in 1993 and now has 20 years of follow-up.  Participants were contacted every 
six months and were seen in the field centers annually through 1999, and again in 2005-06. 
Hundreds of health-related variables were collected at baseline and at the annual clinic visits and 
a fewer number were collected annually or semi-annually by phone throughout follow-up. 
Dependent Variables 
Hosted by The Berkeley Electronic Press
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 Two health-related variables were measured every year after baseline.  Self-rated health 
was a single question, “is your health excellent, very good, good, fair, or poor?”, and “Healthy” 
was defined as being in excellent, very good, or good health (as opposed to fair or poor health).  
Activities of daily living were defined as self-reported difficulty in walking around the house, 
getting out of a bed or chair, feeding, dressing or bathing oneself, and getting to and using the 
toilet.  A person who had no difficulties with any of those activities was defined as “Able”.   We 
summed the number of years when a person was Alive (YOL), Healthy (YHL), Able (YABL), 
and both Healthy and Able (YHABL). 3  These variables have been used as outcomes in other 
publications. 4 5 6 7 8 9 10 
 For the 85% of enrollees who died before 2013, the observed data were complete.   We 
estimated the additional years for the remaining 15%.  For example, for a person who was 65 at 
baseline and still alive 20 years later, the number of remaining years was estimated from persons 
who were age 85 and of the same sex, Healthy and Able status at baseline.  (See Appendix 1).  
These estimates were added to the sum of the observed data to provide lifetime data for 
everyone.  The lifetime sums were the outcome variables for the analyses. 
 
Potential Predictor Variables 
 CHS collected hundreds of variables at the baseline intake.  We sought to identify 
predictors that were associated with the outcomes, and to limit the total number so that they 
could be asked in a short questionnaire designed for lay persons.  Here, we limited potential 
predictors to about 200 variables that had almost no missing values at baseline and that could be 
self-reported by the user. These requirements excluded laboratory test results, clinic 
measurements and lengthy questionnaires, as well as variables asked of only one sex.  The 
variables also needed to be available at the baseline of each of the 4 waves.   Space limitations do 
not permit listing all of the variables initially considered, but they included measures of personal 
history, medical history, physical function, cognitive function, physical activity, social support, 
quality of life, and stressful life events.  (See Appendix 7). 
Waves of Data 
 Missing values of self-reported health and activities of daily living during follow-up were 
imputed by linear interpolation of a person’s observed values over time.  In brief, available data 
were transformed to a scale that included a value for death.  Missing values were linearly 
interpolated over time for each person, and the resulting variables were transformed back to the 
original scale. Details are available elsewhere. 11   About 14% of the possible self-rated health 
data (when person was alive) had to be imputed, and about 29% of the ADL data.  The latter 
number was large because ADL was not collected in the appropriate format from 2000 to 2004.   
 
http://biostats.bepress.com/uwbiostat/paper407
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For this analysis, we created four waves of data, where wave 0 consisted of the baseline 
year and 20 years of follow-up for both cohorts.  Wave 1, for the first cohort only, started 1 year 
after baseline and had 20 years of follow-up from year 1 to 21, and similarly for Waves 2 and 3 
which started 2 and 3 years after the first cohort’s baseline, respectively and included 20 years of 
follow-up. There were thus 5201*4 + 687 = 21,491 potential baseline observations, and because 
some enrollees died in the first 3 years, there were actually 20,876 baseline observations. This 
approach allowed us to use all of the data, while maintaining the same number of years of 
follow-up for both cohorts, increased the number of the oldest persons available for analysis, and 
potentially reduced the likelihood of “healthy volunteer bias” because only about a fourth of the 
waves started at the true baseline.  The disadvantage is that observations were not statistically 
independent (most persons were in the dataset four times).  As described below, that was handled 
by restricting analyses where independence was required to a single wave of data.   
 
2.2 Analysis  
Selection of Predictor Variables 
 The goal was to predict YOL, YHL, YABL, and YHABL for a person with certain 
attributes.  The prediction equations, separate for men and women, needed to include age and the 
baseline values of Healthy and Able. We next screened the potential baseline variables to 
identify a small set of variables that improved prediction.  The variables were screened in two 
stages.  The first stage screened the 200 or so potential variables, as described below and listed in 
Appendix Table 7.1.  The second stage re-screened a subset of variables that users might expect 
to be included (see below), to improve the face validity of the eventual calculator.   Stepwise 
multiple regressions were used for screening. 
Screening for good predictors  
 The first screening forced baseline age, Healthy and Able into the regression, and then 
performed a forward selection regression among all of the remaining eligible baseline variables, 
with an alpha to enter of 0.0001.  This screening used only Wave 0 data, so that observations 
were statistically independent and the significance levels had some meaning.  Variables that were 
selected in all 8 of the regressions (4 outcomes for two sexes) were retained.  The likelihood of 
false discovery was limited by the small alpha level and the requirement that the predictor be 
selected for both men and women. 
Screening to improve face validity  
 The second screening forced in the regression variables chosen above, and then 
performed a forward selection among variables commonly associated with mortality, self-
reported health or functional status in CHS, even though they were not selected in the first 
screen.   A less stringent alpha level of 0.01 was used.  The following variables were considered 
in the second screen:  bed days in past two weeks, blocks walked in the previous week, 
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hospitalization in the previous year, myocardial infarction, stroke, feeling about life as a whole, # 
of difficulties with instrumental activities of daily living (IADL), previous angioplasty, coronary 
bypass surgery, current diagnosis of cancer, taking insulin or hypoglycemic agents, renal disease 
or failure, and body mass index.   Variables were retained if they were selected in all or most of 
the 8 regressions.  This screen was restricted to the Wave 3 data (which began 3 years after 
baseline) to ensure statistical independence and to reduce the healthy cohort bias.  The variables 
selected at this stage were included in the main prediction equation. 
 In order to estimate years of healthy and able life, the final prediction equations used all 
of the selected variables, and were calculated using all waves of the dataset, because statistical 
significance was no longer an issue and the larger sample was important for estimation at the 
oldest ages.   
2.3 Internal and External Validation  
  Internal validation involved random assignment of 80% of the enrollees into a “training” 
sample and the remaining 20% into a “validation ” sample. The 2-stage variable screening was 
repeated in the training sample only, and the resulting prediction equations were applied to the 
validation sample.  The root mean squared error, defined as the square root of the average 
squared difference between observed and predicted values, was calculated. We also calculated 
the % of estimates that were within plus or minus 5 (or 3) years of the observed values.  This 
process addressed the issues of over-fitting because the validation sample was not used in 
creating the prediction equations. Note that this type of validation does not test the specific 
variables chosen or the regression coefficients, but rather whether the methods used to create the 
estimates provided good estimates for the validation sample.   
The external validation used two outside sources of data:  the current U.S. lifetable  [1] 
and unpublished data from a different cohort study. The life expectancies from the current U.S. 
lifetable are estimates of YOL. We compared the lifetable to the CHS estimates of YOL, and 
also to the observed data.  There are no national estimates of YHL, and we found no study that 
was strictly comparable to CHS, which had nearly lifetime follow-up on self-rated health and 
activities of daily living.   Instead, we used unpublished data from the Multi-Ethnic Study of 
Atherosclerosis (MESA), also funded by the NHLBI. 12  MESA enrollees, required to be free of 
heart disease at baseline, have been followed for 10 years to date.  Self-rated health was collected 
at each survey wave.  Using the approach outlined above, we calculated 10-year prediction 
equations for YOL and YHL in CHS, limiting to variables that were available in both CHS and 
MESA, plus a variable indicating heart disease that was set to 0 for all MESA enrollees (see 
findings section). We applied the new CHS equations to the MESA enrollees aged 65 and older, 
and compared the mean observed and predicted values.   
2.4 Creation, Documentation and Beta Testing of the CHS Healthy Life Calculator 
(CHSHLC) 
http://biostats.bepress.com/uwbiostat/paper407
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 We created a web-based calculator (the CHSHLC) that requested the user to provide the 
information for the prediction equations, and then calculated the user’s lifetime expected values.  
The web page includes documentation in a frequently asked question (FAQ) format.  Three 
convenience samples of older adults were invited to use the calculator and provide feedback.  
After each wave we modified the calculator to reflect the user comments.  See Appendix 2 for 
more detail. 
3.0 Findings 
3.1 Predictor Variables Chosen for the CHSHLC 
 Histograms of the four outcome variables are given in Appendix 1.  Descriptive statistics 
are shown in the first four lines of Table 1, and are discussed below. 
  The eligible variables were entered into the regression several stages, as 
previously described.  Analyses were done separately for men and women.  In the first stage, 
baseline age was included both as a linear and a log term, to allow the relationship to be 
nonlinear where it was warranted.  For baseline self-reported health, we included both the binary 
“Healthy” variable (1 if excellent, very good, or good; 0 if fair or poor) and also a recode of 
excellent through poor to 95, 90, 80, 30, and 15 respectively. 13  Baseline Able was coded as 0 if 
the person had difficulty with any of the ADLs, and 1 otherwise.  (CHS had relatively few 
enrollees with 2 or more ADL difficulties).  Baseline HABLE was coded as 1 if the person was 
both Healthy and Able, 0 otherwise. 
 The first screen of about 200 baseline variables selected four predictors: smoking, 
shortness of breath, diabetes, and number of prescription drugs.  Smoking was coded as never, 
former, or current smoker.  After the beta test we added the number of years since quitting for 
former smokers.  Shortness of breath was based on self-report of the symptom when hurrying on 
the level or walking up a slight hill. It was significantly correlated with longer indices measuring 
COPD, CHF, and lack of fitness (not shown) and may be in part a proxy for those conditions. 
Diabetes was coded 1 for persons whose doctor had told them they had diabetes and 0 otherwise.  
Although fasting glucose was also measured at baseline, we used only the self-reported data 
because the calculator would also be based on self-report.  The number of prescription drugs was 
not actually self-reported in CHS.  Rather, enrollees brought their prescription drugs to the initial 
and annual interviews, where they were counted and classified.  The variable was such a strong 
predictor, however, that we created a self-report question for the CHSHLC.   
 The second screen, meant to improve face validity chose 4 more variables: a history of 
MI or stroke, blocks walked in the last week, instrumental activities of daily living (IADL), and 
feeling about life as a whole.  MI and Stroke were combined to a single question in the 
calculator.  Number of blocks walked in the last week is a simple measure of physical activity.  
We changed the wording somewhat from the original questionnaire because nowadays many 
people know how many miles they walk, and the beta testers suggested this change.  The 
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variable was significantly related to the over-all physical activity scale (not shown) which was 
too lengthy to collect for this application.  Instrumental activities of daily living (IADLs) were 
defined as any difficulty with housework, shopping, meal preparation, money management, or 
using the telephone. The number of reported IADL difficulties, used on the log scale, was 
significantly correlated with the Modified Mini-Mental State Exam (not shown), which was 
available but too lengthy to collect for this application.  Feeling about life as a whole (rated from 
delighted (1) to terrible (6)) was not as strong a predictor as the others (was not selected for all 8 
regressions).  But it has the added benefit of being significantly related to the CESD depression 
scale (not shown), which was too long for this application.   
 The descriptive statistics for the variables selected for the calculator and the 4 outcome 
variables are in Table 1.  The first two columns are for Wave 0 (true baseline) only, and columns 
3 and 4 show waves 0-3 combined.  YOL through YHABL are the dependent variables; for 
example, in the complete data set, women averaged 13.43 YOL but only 6.87 YHABL.  The 
averages for men were a little lower.  Mean age at baseline was 73.8 for women and 74.6 for 
men.  Only 48 enrollees were age 90 or older at the true baseline, but the extra waves of data 
provided a total of 245 persons over 90 for analysis (data not shown).   
    [Table 1 about here] 
 
3.2 Predictions 
 The proportion of variability explained, R2, was .37 for YOL, and .41, .40, and .41 for 
YHL, YABL, and YHABL respectively.  In the sex-specific regressions, age alone accounted for 
about 17% of the variability, baseline Healthy and Able for another 13%, the Screen 1 variables 
for 5 or 6%, and the Screen 2 variables account for another 2 or 3%.  Additional information 
about R2 is shown in Appendix Table 3.   
The 8 regression equations are shown in Table 2.  “Coeff” is the regression coefficient 
and p is the significance level in the final equation.  The coefficients should not be over-
interpreted because the variables were chosen by screening for the most significant predictors 
rather than based on theory. The coefficient for age is not easily interpretable because ln(age) is 
also in the equation.  Similarly, Healthy (binary) and self-rated health are both included, as are 
Able and “Healthy and Able”.  None of those coefficients is directly interpretable because of 
multicollinearity.  Three of the remaining variables were used on the log scale (ln(IADL+1) , 
ln(blocks walked + 1), and ln(# of medications+1)), also making their coefficients difficult to 
interpret directly. 
 The remaining coefficients are more directly interpretable.  For example, for women, 
shortness of breath was associated with .6 fewer YOL, 1.2 fewer YHL, 1.0 fewer YABL, and 1.3 
fewer YHABL, after controlling for the other variables in the equation.  For women, diabetes 
http://biostats.bepress.com/uwbiostat/paper407
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was associated with 1.9 fewer YHL,  current smoking with 3.1 fewer YHL, and so on.  Variables 
were highly statistically significant except in the few cases that can be attributed to 
multicollinearity.  The significance levels are not surprising because of the way the variables 
were chosen.  
[Table 2 about here] 
Example of Predictions at Age 70  
Table 3 provides an example of the predictions for 70-year-old women and men at 
several percentiles of health.  For example, in row 1, for 70-year-old CHS women, mean 
observed YOL was 16.04 years, comparing favorably to a mean predicted value of 15.82 years.  
Unlike the lifetable estimate (16.33 years for all 70-year-old-women), we obtained a range of 
estimates based on personal characteristics.  The fifth percentile of the predicted values was 
10.80 years, the median was 16.32 years, and the 95th percentile was 18.98 years.  For 70-year-
old men the estimates of YOL were lower than for women, and the mean was slightly less than 
the lifetable estimate. 
There is no national standard for YHL, YABL, or YHABL.  The tabled results show that 
the mean observed and predicted values are close to each other, and that there is a large range of 
predicted values for both men and women.  The CHSHLC estimates are thus close to the national 
standard (for YOL) and to the observed data, and produce a wide range of estimates rather than 
estimating everyone at the mean.   
[Table 3 about here] 
 
 
3.3 Internal and External Validity 
Internal validity 
 To assess internal validity we repeated the process for creating the prediction rules in the 
training sample and applied the resulting rules to the validation sample.  The same four variables 
were selected in the first screen of the training sample as in the over-all analysis.  Although a few 
variables were different in the second screen, that is to be expected because those were not the 
most consistent predictors. The root mean squared error (RMSE), defined as the square root of 
the mean squared difference between the observed and expected values, was nearly identical in 
the training and validation samples.  For example, RMSE for YOL was 5.96 years in the training 
sample and 6.05 years in the validation sample.  The prediction was thus nearly as good in the 
validation sample as in the training sample.   (See Appendix 4 for the complete RMSE data). 
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Because few of the potential users of the calculator will have any intuition for RMSE, we 
instead present Table 4, which shows the % of estimates that were within plus or minus 5 (or 3) 
years of the observed data.  First consider YOL.  Only 42% of the predicted values for 65-69-
year-olds were within + 5 years of the observed values, but the results improved with age.  
Prediction was better for YHL, YAL, and YHABL than for YOL.  Similar results are given in 
the lower part of the table which shows the percent of estimates within 3 years of the observed 
values.  Related tables for the % more than 5 years away from the observed are in Appendix 5. 
The percent above and below the 5-year interval were roughly comparable, and so can be 
approximated from Table 4 as (100-% within 5 years)/2. Personalized percentages are presented 
in the CHSHLC, taken from a regression of a binary variable “within 5 years” on age, sex, and 
the estimate (equation not shown).  
[Table 4 about here] 
External Validity 
 We first compared predicted YOL to the lifetable estimates. For the entire CHS sample, 
the mean lifetable values were about .07 years higher than the predicted YOL for men and were 
about .4 years lower for women, which is reasonably close.  (But in Table 3, at age 70, the mean 
lifetable values were about .76 years higher for men and about .51 years higher for women, 
suggesting worse agreement at younger ages.)  In Table 4, only 36% of the lifetable values for 
65-year-olds were within + 5 years of the observed values, as compared to 42% for YOL. 
Agreement between YOL and the lifetable values was quite good on average.  Thus, today’s 
lifetable applied reasonably well to the CHS cohort in 1990.  Predicted YOL had a slightly 
smaller RMSE than the lifetable estimates, probably because it included covariates (data not 
shown).   
We calculated new 10-year CHS prediction regressions using only the variables that were 
available in both the MESA and CHS datasets, and applied the prediction equations to the MESA 
data.  Those variables, and their mean values, are shown in Appendix Table 6.1.   The MESA 
population was healthier than the CHS population, because of the difference in eligibility criteria 
described above.  The 10-year CHS predictions underestimated observed MESA data by .3 years 
for YOL and .6 years for YHL for women, and by .6 and .5 years respectively for men.  The fit 
was better at the younger ages.   MESA began data collection in about 2000, ten years later than 
CHS. This under-prediction may suggest that the CHSHLC will be a little conservative for 
today’s users, on the order of 6 months in the first 10 years.  These results did not involve the 
actual variables or equations used in the CHSHLC.  The MESA comparison was primarily a 
demonstration that the method used to create the CHSHLC could provide reasonable predictions 
in a later dataset. 
3.4 The CHS Healthy Life Calculator (CHSHLC) 
http://biostats.bepress.com/uwbiostat/paper407
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 The CHSHLC is currently available at http://diehr.com/paula/healthspan/.  It will be 
moved to the CHS webpage upon final approval, and will be referenced that way in the 
published version of this manuscript.  Dissemination will be through the web page, through the 
published paper, and through word of mouth.   
For an example of the CHSHLC, consider “Mary”, who is 70 years old and would like to 
put off making any major changes until she is about 80 (10 years).  Mary is quite healthy, giving 
the best possible answers to all of the CHSHLC questions.  Her prediction results are here.   
You answered that you are a woman, 70 years old. In our database, people like you (who gave 
similar answers on these questions) lived, on average, to be 90.0 years old. During these 
remaining 20.0 years of life, these people enjoyed 16.8 years of Healthy life, 16.5 years of Able 
life, and 14.2 years in which they were both Healthy and Able. 
▼How likely is it that I'll do better? 
 
About half of the people like you did better than their estimates. 
Furthermore... 
29% had more than 25.0 years of life (YOL) 
28% had more than 21.8 years of healthy life (YHL) 
29% had more than 21.5 years of able life (YAL) 
26% had more than 19.2 years of healthy and able life (YHABL) 
 
▼How likely is it that I'll do worse? 
 
About half of the people like you did worse than their estimates. 
Furthermore... 
29% had fewer than 15.0 years of life (YOL) 
28% had fewer than 11.8 years of healthy life (YHL) 
29% had fewer than 11.5 years of able life (YAL) 
26% had fewer than 9.2 years of healthy and able life (YHABL) 
 
 
4.0 Discussion 
 We created prediction equations for lifetime YOL, YHL, YABL, and YHABL using a 
unique dataset that had 200 potential predictors and 23 years of follow-up.  From them we 
created a usable calculator, the CHS Healthy Life Calculator, for persons aged 65 and older.  
Documentation is provided about the methods used and the probable accuracy of the predictions.   
 The predictions should be useful for planning.  For example, Mary, who wants to avoid 
making any plans for 10 years, might reason that she will be both healthy and able for 14.2 years, 
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which would allow her to defer making changes until she is 80.   But she also has about a 26% 
chance of having fewer than 9.2 YHABL, and so might prefer to make her plans sooner. 
4.1 Other calculators 
We have compared our YOL estimates to the U.S. lifetable. There are other predictors of 
life expectancy available on the internet, but there is no formal way to compare them to the 
CHSHLC predictions, because of their lack of documentation or their use of variables not in the 
CHS dataset.  We have found no other individual-level predictions of YHL or YABL.    
4.2 Limitations 
 The CHS data were well-suited for the development of a health-prediction calculator 
because few assumptions needed to be made about lifespan and years of healthy life.  That is, the 
outcomes were completely observed for 85% of the sample, and only the final few years needed 
to be estimated for the others.  But the CHS enrollees may not have been representative of all 
older adults.  People under active treatment for cancer, wheelchair users, or unable to cognitively 
respond to questionnaires at baseline were ineligible, and the likely healthy volunteer effect may 
also have contributed to a healthier sample.  If so, predictions based on them could be too 
optimistic.  Because CHS did not start out with many people who were very old or very sick, 
predictions may be less accurate for such people.  Our inclusion of later waves of data may have 
mitigated these effects. Since our average YOL predictions were close to the values in the 
current U.S. lifetable, these potential problems may not have existed, or their effects may have 
averaged out.   
We restricted the prediction analyses to CHS variables that could be self-reported and 
were rarely missing.  Some important features specific to the health of users may not have been 
taken into account.  Their parents may have lived well into their 90s, or they may have a serious 
disease that was not known in the CHS dataset.  Those specific features may have been 
accounted for by the health and medication information that were used.  The small improvement 
in the overall R2 at each step suggests that additional variables would not have had much overall 
effect, even if they did improve predictions for some users.   
We could instead have chosen predictor variables in advance, based on theory, and 
emphasized mutable health behaviors. But that approach might have missed the strongest 
predictors, such as shortness of breath, or required a much longer calculator.  Our approach does 
not allow us to make individual recommendations about how a user might improve her health, 
but such recommendations were never our intent.  Ample health advice is available from other 
sources. 
Other screening approaches might have selected different or even better predictors. We 
eliminated a large number of variables from consideration, and some of them might have been 
strong predictors in some of the regressions.   We might have used a more complex regression 
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model. Interactions with age were considered but not used because they seemed to contribute to 
over-fitting.  Linear regression was used because our goal was to estimate average YOL, YHL, 
YABL, and YHABL on the original scale.14   Forward selection was a practical approach for 
screening the hundreds of variables available here.  For comparison, we considered another 
screening approach with an alpha level of only 0.01 for inclusion and no restriction that the 
variables be the same in all 8 regressions.  This approach ended up with about 3 times as many 
predictor variables in each equation, probably included more variables that were significant by 
chance alone, and improved R2 by only about 0.02.  (See Appendix 6).  We feel that the 
approach used here was appropriate for our purposes. 
 The CHSHLC assumes that a user who is 70 years old today is similar to a person in CHS 
who was 70 in 1990.  There have been many improvements in public health, health behaviors, 
and health care since then, suggesting that the CHSHLC may be pessimistic.  On the other hand, 
changes such as the increases in obesity and in antibiotic resistant bacteria could have the 
opposite effect.  (Lifetables rely on a related assumption that mortality rates calculated for 
persons currently aged 70 will still apply when a person born today reaches 70.)  The strong 
agreement between the current lifetable and YOL suggests that this concern may not be serious, 
although the MESA comparison may suggest some underestimation.  
4.3 Are YHL and YABL important to older adults?   
 Older adults may disagree about the relative importance of YOL and YHL.  For example, 
in one recent study of heart failure, about half of patients preferred treatments that prolonged 
survival while a different group favored strategies that reduced survival time but improved 
quality of life. 15  Persons for whom survival is the main consideration might obtain predictions 
elsewhere.  But persons who want to estimate their YHL and YABL will need to use our 
calculator. 
Older adults are also concerned about cognitive decline.  Being healthy and able does not 
guarantee that a person will be cognizant.  CHS enrollees had to be sufficiently cognizant to be 
enrolled, and we can assume that users of the CHSHLC will also be reasonably cognizant now.  
So the issue is how many remaining years of cognizant life there were.  On average, cognitive 
function declines at a slower rate than do physical health and ADL ability. 16  17  Based on data 
collected in the first 9 years of the study, the great majority of older adults (62% at age 90, and 
about 75% at younger ages) have more future years of “cognizant life“ than years of  ”healthy 
and able” life.  (see appendix 8 of the technical report).  In a second calculation, using 20 years 
of data on cognition (some years using a different cognition instrument, with many years 
imputed) we also found that about 75% of the CHS enrollees had more YCOGL than YHABL.   
Therefore, estimated YHABL is usually a lower bound on years of cognizant life, and most users 
may use YHABL for planning purposes.  
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 In a final analysis we checked whether a selection of variables that were excluded from 
making the calculator might have made better predictions.  Technical report 9 shows these 
results, which did not indicate any variables that would have been worth trying to incorporate.  
The methods that we used here were probably satisfactory.   
Conclusion 
 We created a personalized and well-documented calculator for years of life, years of 
healthy life, and years of able life. The YOL estimates from the CHSHLC are, on average, 
comparable to the current US Life tables but give a wider range of estimates.  Most important, 
the calculator also estimates the number of years in which the user will be healthy and/or able to 
perform the activities of daily living, which are relevant to many life decisions.  This seems to be 
the only published calculator for years of healthy, able, or healthy and able life.  It is also one of 
the few that provides information about the accuracy of the estimates.  For that reason, the 
CHSHLC should be a useful planning tool for older adults. 
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Table 1:  Descriptive Statistics for Prediction and Outcome Variables 
 
   
Baseline Wave All Waves 
   
Women Men Women Men SD(all) 
Sample Size 
 
3393 2495 12047 8829 
 YOL, years 
  
14.29 11.52 13.43 10.69 7.25 
YHL, years 
  
9.71 8.36 9.11 7.69 6.66 
YABL, years 
  
9.96 8.88 9.21 8.04 6.92 
YHABL, years 
  
7.47 6.79 6.87 6.12 6.32 
Age, years 
  
72.52 73.28 73.80 74.62 5.61 
Healthy at baseline, %  
  
0.73 0.76 0.76 0.77 0.42 
Able at baseline, % 
  
0.90 0.94 0.87 0.91 0.32 
Healthy and Able at 
baseline, % 
 
0.70 0.74 0.70 0.73 0.45 
Short of Breath, % 
 
0.42 0.34 0.41 0.32 0.48 
Diabetes, % 
  
0.11 0.14 0.10 0.14 0.32 
# Prescription Meds 
 
2.48 2.17 2.55 2.29 2.23 
Current smoker, % 
 
0.12 0.11 0.12 0.09 0.31 
Former smoker, % 
 
0.30 0.57 0.30 0.58 0.49 
Never smoked, % 
 
0.57 0.32 0.58 0.33 0.50 
Yrs since quitting, *  19.08 22.62 19.01 22.81 13.70 
Blocks walked /wk,  
 
32.00 49.38 29.57 45.85 52.59 
# of IADL Difficulties 0.44 0.26 0.49 0.36 0.90 
Feeling about Life (1-7) 2.36 2.17 2.46 2.31 0.91 
MI or Stroke, % 
 
0.12 0.24 0.12 0.24 0.38 
       
*former smokers only       
Entries in table are mean values unless otherwise denoted.  The variables marked “%” are 
actually proportions, but the % symbol was used for succinctness.
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Table 2  
Prediction Equations (Regression Coefficients and p-values) 
COEFFICIENTS FOR WOMEN
YOL YHL YABL YHABL
coeff p coeff p coeff p coeff p
(Constant) 357.818 0.000 523.610 0.000 646.474 0.000 544.266 0.000
Age 0.651 0.002 1.523 0.000 1.918 0.000 1.686 0.000
ln(age) -91.579 0.000 -146.703 0.000 -181.743 0.000 -154.581 0.000
Healthy -1.070 0.029 -3.225 0.000 -2.855 0.000 -4.555 0.000
SRH (0 to 100) 0.052 0.000 0.111 0.000 0.059 0.000 0.094 0.000
Able 0.269 0.307 -0.709 0.004 1.106 0.000 -0.632 0.005
HABLE -0.051 0.881 1.864 0.000 1.737 0.000 3.330 0.000
Shorness of Breath -0.590 0.000 -1.173 0.000 -1.044 0.000 -1.280 0.000
Diabetes -1.993 0.000 -1.923 0.000 -1.721 0.000 -1.521 0.000
ln(# of meds) -0.606 0.000 -0.834 0.000 -0.907 0.000 -0.975 0.000
Current smoker -3.479 0.000 -3.141 0.000 -2.841 0.000 -2.505 0.000
quit < 5 years -2.222 0.000 -2.338 0.000 -1.813 0.000 -1.613 0.000
quit 5-9 years -1.969 0.000 -1.630 0.000 -1.588 0.000 -1.238 0.000
quit 10-14 years -1.669 0.000 -1.563 0.000 -1.635 0.000 -1.269 0.000
quit 15-19 years -1.596 0.000 -1.228 0.000 -1.202 0.000 -1.009 0.000
quit 20+ years -0.755 0.000 -0.406 0.005 -0.598 0.000 -0.462 0.000
ln(blocks + 1) 0.381 0.000 0.351 0.000 0.487 0.000 0.402 0.000
ln (# IADL difficulties) -1.026 0.000 -0.935 0.000 -1.650 0.000 -1.162 0.000
Feeling about Life as a Whole -0.175 0.006 -0.387 0.000 -0.110 0.063 -0.305 0.000
MI or Stroke -2.139 0.000 -1.592 0.000 -1.403 0.000 -1.006 0.000  
COEFFICIENTS FOR MEN
YOL YHL YABL YHABL
coeff p coeff p coeff p coeff p
(Constant) 300.339 0.000 405.229 0.000 468.808 0.000 422.927 0.000
Age 0.518 0.022 1.092 0.000 1.253 0.000 1.201 0.000
ln(age) -76.107 0.000 -111.684 0.000 -128.981 0.000 -117.919 0.000
Healthy -0.475 0.402 -3.333 0.000 -2.641 0.000 -4.445 0.000
SRH (0 to 100) 0.035 0.000 0.099 0.000 0.051 0.000 0.084 0.000
Able 0.053 0.871 -0.976 0.001 1.062 0.001 -0.653 0.019
HABLE 0.255 0.545 1.744 0.000 1.816 0.000 3.216 0.000
Shorness of Breath -0.635 0.000 -1.118 0.000 -0.845 0.000 -1.082 0.000
Diabetes -1.643 0.000 -1.611 0.000 -1.609 0.000 -1.473 0.000
ln(# of meds) -1.263 0.000 -1.155 0.000 -1.214 0.000 -1.044 0.000
Current smoker -3.631 0.000 -3.179 0.000 -3.250 0.000 -2.825 0.000
quit < 5 years -2.731 0.000 -2.361 0.000 -2.131 0.000 -1.992 0.000
quit 5-9 years -2.652 0.000 -2.265 0.000 -2.205 0.000 -1.902 0.000
quit 10-14 years -1.728 0.000 -1.169 0.000 -1.406 0.000 -1.030 0.000
quit 15-19 years -1.032 0.000 -0.795 0.000 -1.199 0.000 -0.959 0.000
quit 20+ years -0.436 0.002 -0.511 0.000 -0.521 0.000 -0.508 0.000
ln(blocks + 1) 0.388 0.000 0.281 0.000 0.389 0.000 0.284 0.000
ln (# IADL difficulties) -1.205 0.000 -0.845 0.000 -1.181 0.000 -0.834 0.000
Feeling about Life as a Whole -0.269 0.000 -0.411 0.000 -0.180 0.007 -0.329 0.000
MI or Stroke -1.806 0.000 -1.442 0.000 -1.466 0.000 -1.224 0.000
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Table 3  
Descriptive Statistics for Observed and Predicted Variables 
 for Men and Women aged 70 at Baseline 
 
WOMEN (Lifetable = 16.33 YOL) 
 MEAN PERCENTILES of Predicted  
 Observed Predicted 5% 50% 95%  
YOL 16.04 15.82 10.80 16.32 18.98  
YHL 11.03 10.96 3.57 11.72 15.22  
YABL 11.65 11.48 5.49 12.05 15.18  
YHABL 8.71 8.67 2.13 9.40 12.70  
       
MEN (Lifetable = 14.03 YOL) 
 MEAN PERCENTILES OF PREDICTED 
 Observed Predicted 5% 50% 95%  
YOL 13.47 13.27 7.69 13.68 17.11  
YHL 9.76 9.52 2.74 10.21 13.78  
YABL 10.69 10.52 4.32 11.04 14.39  
YHABL 8.36 8.18 1.88 8.84 12.06  
Hosted by The Berkeley Electronic Press
18 
 
 
 
Table 4  
Percent of predictions within 5 (or 3) years of observed data 
By Age and Outcome Measure 
 
Percent of Predictions within 5 years of Observed
36 42 55 48 58
49 55 68 62 73
59 67 78 76 83
73 76 85 88 91
88 82 84 89 91
98 78 78 84 86
100 100 100 100 100
100 100 100 100 100
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Lifetable YOL YHL YAL YHABL
 
Percent of Predictions within 3 years of Observed
25 29 34 29 36
32 35 46 40 50
39 42 54 52 61
49 51 63 63 70
59 61 65 73 73
76 60 62 61 65
67 80 67 80 87
100 100 100 75 75
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Lifetable YOL YHL YAL YHABL
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8  
Appendix 1 
Creation of Dependent Variables 
 The main text describes YOL, YHL, YABL, YHABL.  These quantities were created as 
follows.   
 A variable named YOL_20 was calculated as the number of years that each person 
(wave) lived during his/her 20 years of follow-up.  YHL_20 is the number of years in which she 
was Healthy.  YABL_20 is the number of years in which she was Able.  YHABL_20 is the 
number of years in which she was both Healthy and Able.   The outcomes as a group are referred 
to as “Years_20”. 
 We needed lifetime values (Years_life).  For the 85% of persons who died before 2013, 
Years_life was known.   We estimated the remaining years for the 15% of persons who were still 
alive in 2013, as follows.  Using all waves of data, we regressed Years_20 on baseline age, sex, 
Healthy and Able (including some transformations).  This equation was used to estimate the 
remaining years.  Thus, for a person who was 65 at baseline and still alive 20 years later, the 
estimated number of remaining years for a person age 85 and of the same sex, Healthy and Able 
status at baseline was used to generate a random variable from the Poisson distribution with the 
same mean as that estimate.  That random value was then added to Years_20 to provide 
Years_life.  These estimates should have been reasonable, on average. 
 The resulting lifetime summary variables were named YOL_life, YHL_life, YABL_life 
and YHABL_life.  These were the outcome variables used for the prediction analysis.  In the 
main text, “_life” is dropped, and for instance YHL_life is referred to simply as YHL. 
 Histograms of the four dependent variables are shown below, for wave 0 only (the true 
baseline).  The histograms have attractive distributions except at year 20.0, for YOL, where too 
many of the people still alive at year 20 were estimated to survive exactly 20 years.  We tried 
various means to correct this anomaly, but each attempt caused a different problem.  The 
problem may be due to the extrapolation to year 20 that was necessary in some cases. Or perhaps 
the regression estimates used to extend the data worked less well for YOL.  This is the version 
used, and we believe that the averages of the extensions are reasonable, since they were 
calculated from real data.  They affect only the last few years for 15% of the cases.  The 
histograms for YHL and YHABL are the most attractive.  The histogram for YAL (YABL) 
probably reflects that we had to impute years 10-14 entirely (except for the deaths) because the 
variable was not collected in a usable form in those years. 
 It may be surprising that about 800 persons in this (presumably) positively selected 
sample have no years of healthy and able life (YHABL = 0).  At baseline, the here is the 
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distribution of Healthy and Able for those persons.  Only 198 were neither Healthy or able; 73 
were Healthy but not Able; 364 were Able but not Healthy; and 206 were both healthy and able, 
for a total of 841.  How can people with no YHABL have been both healthy and able at baseline?  
That is because the graph calls all persons with 0 to .999 as 0.  So if they were healthy and able 
at baseline but because unhealthy and/or unable and/or dead 1 year later, then would  have a 
fraction, and be included in the zero category. 
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Figure 1.1  Years of Life (life expectancy)  (YOL) 
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Figure 1.2  Lifetime years of Healthy Life  (YHL) 
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Figure 1.3   Lifetime Years of Able Life (YABL) 
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Figure 1.4  Lifetime years of Healthy and Able life  (YHABL) 
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Appendix 2 
Beta Tests of the CHSHLC 
 We conducted three waves of beta tests on different convenience samples.  A few of the 
insights gained were mentioned in the main paper.  We had intended to make the questions on 
the CHSHLC  identical to those on the 1990 baseline questionnaire.  However, beta testers had 
problems with the wording of some of the questions, felt that there was not enough credit given 
for walking and length of smoking cessation, etc.   More detailed response categories were added 
for some of the questions. 
 We believe that the main value of the CHSHLC is that it is well-documented, but beta 
testers did not usually read the documentation. (The page count for the documentation page is 
less than 40% of the page count on the main page).  As a response, we added more detail to the 
predictions themselves, to emphasize the amount of possible variability in the predictions. 
We originally took a user-friendly tone.  However, the beta testers did not seem to treat 
the CHSHLC seriously, and so we changed the tone to be more serious and professional.  
Finally, beta testers usually mentioned their YOL estimate, rather than discussing their 
YHL and YABL estimates which we thought were a major contribution of this research.  We 
changed the text somewhat to further emphasize the non-mortality outcomes.  If older adults are 
not interested in being healthy and able, then the use of the CHSHLC may be limited, since the 
U.S. Lifetable is readily available and seemed to be about as accurate as our YOL estimates.    
Some users questioned why certain variables were not used as predictors.  Some variables 
were never collect in CHS.  Others were ineligible because they could not easily be self-reported.  
The remainder did not enter because they were not strong predictors after controlling for the 
variables already in the equation.  This is explained in detail in the documentation.   
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Appendix 3, 
 More about R2 
 
Table 3.1 provides additional R2 information.  The top half (first column) is for 
regression of the predicted value on the observed value ( R2 from .37 to .408).  This gives the 
total R2 including the effect of sex, which doesn’t show up in the sex-specific calculations.  The 
next column shows that a regression with only age and sex and interactions accounts for 22.9% 
of the variability in R2, 15.6 for YHL, etc.   Thus,  the CHSHLC explains about 40% of the 
variability, and on the order of half of the explained variability is due to age and sex. 
Appendix Table 3.1  
 
 
The lower part of the table shows the R2 at each step in the sex-specific regressions.  For 
example, in YOL for women, 21.2% of the variability was explained by age (and log age), which 
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rises to 27.2% when the  Healthy and Able variables were added, to .311 when the screen 1 
variables were added,  and to .377 overall.  The rightmost four columns show the change in R2 at 
each step, and the bottom line shows the mean across the four regressions.  For  YHL for women 
, 14.5% of the variability is accounted for by age alone, another 18.2% from healthy and able, 
another 4.7% for the screen 1 variables, and another 2.2% for the screen 2 variables.  Averaging 
across the four equations, for women, Screen 1 and Screen 2 accounted for similar amounts of 
variability, while for  men, the screen 1 variables accounted for twice as much additional 
variability as the screen 2 variables.   A general conclusion is that there were diminishing returns 
at the four steps.   
 We might have used a different screening strategy.   For example, what if we had not 
required the same variables to enter in all 8 regressions during the first screening?  In Appendix 
Table 3.2, the first column shows that if alpha = .0001, only 4 to 6 variables would have entered, 
and they were not always the same variables.  The R2 was not much higher than shown in 
Appendix Table 3.1.   
  The next columns show what would have happened if we did not require variables to be the 
same in all 8 regressions,  and used an alpha = .01 instead of .0001.  Two or three times as many 
variables entered.  The increase in R2 , shown in the final column, however, was quite small.  The 
improvement was on the order of .01 or .02, and there would undoubtedly be considerable 
slippage due to the large number of variables considered and the lack of restrictions. 
 We conclude that a different screening strategy would have required a much longer 
questionnaire, possibly including more variables significant by chance alone, and that this 
revised strategy not have explained much more variability than the strategy that we used. 
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Appendix Table 3.2 
Effects of Alternate Screening Strategies 
 Alpha = .0001 Alpha = .01   
 # VARS 
ENTERED 
R2 # VARS 
ENTERED 
R2 INCREASE 
IN R2 
 
FEMALE       
YOL 4 .296 12 .315 .019  
YHL 5 .369 10 .380 .011  
YABL 5 .347 11 .361 .014  
YHABL 6 .377 10 .386 .009  
MALE       
YOL 4 .298 13 .324 .026  
YHL 4 .366 11 .387 .021  
YABL 4 .321 13 .346 .025  
YHABL 4 .361 12 .386 .025  
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Appendix 4 
Root Mean Square Error for Training and Validation Samples 
The root mean square error for the two samples is in the following table.  For example, RMSE 
for YOL was 5.8868 in the training sample and 5.9635 in the validation sample, only slightly 
larger.  The RMSE for the validation sample is about .1 years larger than that for the training 
sample, on the order of 2% larger.  This indicates very little slippage or overfitting.   
 
Report 
training YOL YHL YAL YHABL 
validation sample Mean 5.9635 5.0742 5.5083 4.8278 
N 7364 7364 7364 7364 
Std. Deviation .00000 .00000 .00000 .00000 
training sample Mean 5.8868 4.9314 5.4033 4.6987 
N 13512 13512 13512 13512 
Std. Deviation .00000 .00000 .00000 .00000 
Total Mean 5.9139 4.9817 5.4404 4.7442 
N 20876 20876 20876 20876 
Std. Deviation .03664 .06824 .05017 .06166 
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Appendix  5 
% of Predictions more than 5 years from the Observed 
 Table 4 in the main paper showed the % of predictions that were within plus or minus 5 
years of the observed values.   Appendix Table 5.1 shows the % of predictions that were more 
than 5 years away from the observed values.  For example, at age 65, 28% of the Lifetable 
estimates were 5 years higher than the observed, as were 26% of the YOL estimates, 21% of the 
YHL estimates, and so on.  These percentages became smaller with age.  (Those for 90 and 
above should probably be ignored because of the small sample size at those ages).   Appendix 
Table 5.2 is the % of predictions more than 5 years lower than the observed.  It is notable that the 
% above and below are quite similar.  As a simplification, then, we can approximate these 
quantities from the % data in Table 4, as (100-%)/2.  This approximation was used in the 
CHSHLC. 
Appendix Table 5.1 
 Percent of Predictions more than 5 years higher than Observed 
 
  Lifetable YOL YHL YAL YHABL 
65.00 28 26 21 25 20 
70.00 25 21 15 18 12 
75.00 20 17 10 10 6 
80.00 11 12 6 5 3 
85.00 2 6 7 5 4 
90.00 0 9 8 5 5 
95.00 0 0 0 0 0 
100.00 0 0 0 0 0 
 
Appendix Table 5.2   
 Percent of Predictions more than 5 years lower than Observed 
 
  Lifetable YOL YHL YAL YHABL 
65.00 32 29 22 24 21 
70.00 25 23 16 19 14 
75.00 21 16 12 13 10 
80.00 15 11 8 6 5 
85.00 10 10 8 5 3 
90.00 2 10 11 7 5 
95.00 0 0 0 0 0 
100.00 0 0 0 0 0 
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APPENDIX 6 
CHS versus MESA (External Validation) 
 The external validity check applied estimates developed in the CHS data to the MESA 
data, which began about ten years later than CHS.  As MESA had only 10 years of follow-up, we 
calculated ten-year outcomes, YOL10 and YHL10.  We were also restricted to predictor 
variables available in both CHS and MESA.  The means of the outcomes and of the predictors 
are in appendix Table 6.1.  There were 3900 persons 65 and older  in MESA as compared with 
20876 in the 4 waves of CHS.  MESA  enrollees had higher YOL and YHL.  This is partially 
explained by the eligibility criteria, as seen in the fact that on average MESA enrollees were  
younger, healthier, less short of breath, less diabetic, and (by requirement) none had had a 
previous MI or stroke.  Smoking rates were similar, and CHS had slightly lower depression 
scores (less depressed). 
 
Appendix Table 6.1 
 
Mean of Regression Variables in CHS and Mesa
External  Validi ty Check
20876 3900
8.54 9.75
6.45 7.97
74.14 69.64
.77 .89
72.72 79.90
.37 .14
.12 .15
.42 .41
.11 .09
5.36 7.01
.17 .00
SumSample Size
MeanYOL (10)
MeanYHL (10)
MeanAge
MeanHealthy
MeanHealth
MeanShort of Breath
MeanDiabetes
MeanFormer Smoker
MeanCurrent Smoker
MeanDepression
MeanMI or Stroke
CHS Mesa
 
For the validation,  a regression of YOL10 and YHL10 on these prediction variables was 
performed in the CHS sample and then applied to the MESA sample.  The observed and 
predicted values in the MESA dataset are shown in Appendix Table 6.2.  
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Appendix Table 6.2 
Predicted versus Observed in the MESA sample 
 YOL10 YHL10 
 Predicted Observed Predicted Observed 
MESA female 9.56 9.80 7.12 7.71 
MESA male 8.87 9.42 7.31 7.80 
MESA all 9.23 9.62 7.20 7.76 
 
  
  
The observed values were close to the predicted values, but were a little higher, on 
average.   For example, for YOL10, MESA females were predicted to average 9.56 YOL but 
actually averaged 9.80 YOL.  Differences averaged about half a year.  That the MESA cohort did 
a little better than would have been predicted from the CHS data might be taken as evidence that  
the CHS estimates in the main analysis will underestimate YOL and YHL for current users.  
However, prediction equations in the main paper and here have different predictors and different 
outcome variables, suggesting it is unwise to over-interpret these apparent biases.   
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Appendix 7 
Additional Detail about Screen 1 
The initial screen was based on all of the variables available at baseline.  The datafile we 
used (called ATVITW for All the Variables in the World) was created for a different paper, 
published in 1999. 18  That paper required all of the variables to be dichotomized, with any 
coding inconsistencies corrected before dichotomization. Continuous variables were 
dichotomized at the mean. The process also, unfortunately, lost the variable labels, and the 
software used at that time required that all variable names be short, and often not very 
interpretable.   Since that time, the baseline files have changed somewhat,  and it is not simple to 
re-attach all of the labels.  We chose to screen the variables in the ATVITW file to find good 
predictors and then to attach the labels only for the chosen variables.  After the first screening, 
the full (non-dichotomized) version of each selected variable was used for further analysis. 
In the current prediction paper, we kept only those variables with at least 5800 known 
cases, because a “forward selection” first removes all of the people with missing data on any 
variable and can result in a very small analysis file.  Requiring that 5800/5888 cases of each 
variable be known allowed resulted in a dataset of 4198 persons for screening 1.  Once the 
variables were selected, the number of complete cases for the final model was much larger 
(n=5813 persons).  Finally, we used  only variables that could easily be self-reported by the user 
of the CHSHLC.  This of course removed most of the laboratory results and measurements made 
in the clinic, in addition to lengthy scales that could not easily be collected in a brief on-line 
questionnaire.  Clearly, other choices could have been made, and might have resulted in different 
variables being chosen for the calculator. 
The variables used in the screen 1 regression are listed in Table 7.1.   This listing will 
probably not be useful to persons who are not CHS investigators.  Also note that a few variables 
are listed more than once (e.g., several variants of age), due to different choices for the coding 
(original scale and log scale). 
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Appendix Table 7.1 
Variables in atvitw_20_years_12.sps  (Screen 1, alpha = .0001)
agebase antpsy06 choladj hctzk06 ohga06 tvsee
lage anyace chstpn hdl44 ostrd06 ues
HEALTHY anybeta clblmod healt01 ovrwt120 urcos06
vgscore anydiur clot12 hearprob ovrwt130 vaso06
ADLNO anyone corart hip13 pneumon vasod06
pressm anyvaso cre44 hrtsur ppi06 verir06
diabet arth01 creadj hshold01 premar06 versr06
shtbrt asa06 diet25 htnmed06 pknsinrx visprob
mibase aspirin dig06 hyper prob06 waist13
angbase aspr06 dihir06 IADL progst06 wakeup
chfbase asthcur dihsr06 implan pvdl06 warf06
strkbase avzmdia dizzy16 initdate read weakp
tiabase avzmsys dizzy22 iprtr06 recogn weight13
chd bal22 dizzyp istrd06 roseang xoi06
anyclin basq06 dltir06 k44 roseic
diag01 benzod06 dltsr06 kadj score03
abtleg beta06 domgrip kcl06 slf106
ace06 betad06 ecgafib kspr06 slf206
aced06 birthdt emphysem laxatv06 slpill06
ADL bleed12 estrgn06 lescr05 spin22
age5 block04 eversm lipid06 stht13
alb44 bphi extart loop06 stt
albadj bpssur faint12 losbal22 sttn06
alpha06 bronch fall22 miblmod supdia16
alphad06 calc06 fat25 niac06 sympth06
anar1a06 caroti fatigp nifir06 tca06
anar1b06 cbd fibr06 nifsr06 tcap06
anar1c06 ccb06 flush06 nitro06 tele
anar306 ccbir06 fshoil06 nsaid06 thry06
anblmod ccbsr06 h2b06 ntca06 tiblmod
anthst06 chdblmod hctz06 ntg06 trig44  
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Appendix 8 
Cognition and YHL and YABL. 
 
 In addition to concern about their future Health and Ability, older adults also have 
concern about cognitive decline.  CHS did not collect lifetime data on cognition, but it did collect 
the Modified Mini Mental State Exam (a.k.a. 3MSE) from 1990 to 1999.   The original 30-point  
MSE, with a cutpoint of 23, has 88% sensitivity and 86% specificity to detect dementia, although 
it is less sensitive to mild cognitive impairment.19  Later cognition data are described below.   
 We used two approaches to examine how “healthy and able” was related to 
“cognizant”, defined here as a 3MSE score of 80 or above.  We chose the cut-off of 80 because 
94% of the CHS enrollees had a score above 80 at baseline.  (More specifically, 63% had a score 
above 89 and another 31% had a score from 80 to 89.)  While a score above 80 does not 
guarantee that a person had no cognitive impairment (the 3MSE is a screener for dementia that is 
usually followed up by other tests),  it does suggest that the person was sufficiently cognizant to 
be expected to participate in CHS for 3 years. 
Two approaches were used.  The first used only data from chs year 2 to chs year 11, 
when the 3MSE was measured for everyone.  The second approach used data that were collected 
later on, but using a different instrument (the telephone interview for cognitive status, or TICS).  
20No cognition data at all were collected in CHS years 12 through 17, or year 19, so that 
information plus any missing values had to be imputed.  We used the general approach given 
elsewhere 21  with the addition that the “Cognizant/not cognizant” dummy variables were post-
adjusted during CHS years 12-15 to make the average population value the same as a straight 
line drawn from year 11 to year 18, when data were available.  (This post-adjustment was 
probably needed because a large number of persons died in years 12-17, and the imputation 
method we used tended to over-state the terminal drop in cognition). 
 
1. Data from CHS years 2 through 11 only. 
 We used the available information to examine the relationship between  Years of 
Healthy and Able Life (YHABL) and years with a 3MSE score greater than 80  (Years of 
“Cognizant” life (YCOGL)).   
 We calculated the number of years in which a person was cognizant (had a 3MSE>80) in 
the 9 years of follow-up available.  We compared YCOGL to YHABL, calculated over the same 
time period, noting how often YCOGL was better (higher), the same, or worse (lower) than 
YHABL.  Table 8.1 shows the results.  The distribution varies by age.  YCOGL was greater than 
Hosted by The Berkeley Electronic Press
38 
 
or equal to YHABL in all but 8.5% of the cases for ages 65-74.  Even at the oldest age, all but 
36.8% had YCOGL>YHABL.    
Table 8.1 
Percent where YCOGL is better, same, or worse than YHABL 
 
bsw Better, Same, Worse * agecat10 Crosstabulation 
% within agecat10       
  agecat10 
  65-74 75-84 85-95 95+ Total 
Better, Same, Worse yhabl < ycog 54.4% 56.2% 52.3% 39.3% 54.8% 
yhabl = ycog 37.0% 30.1% 22.9% 23.9% 31.3% 
yhabl>ycog 8.5% 13.7% 24.8% 36.8% 13.9% 
Total 100.0% 100.0% 100.0% 100.0% 100.0% 
 
 
  A crude multi-state lifetable calculation 
 We used the numbers in Table 8.1 for a crude calculation.  From the table, for persons 
starting out at age 95+, 36.8% have YCOGL<YHABL, and 63.2%  have YCOGL >YHABL.  
There were few people at this age at baseline, and this number is unreliable. 
Now consider 100,000 women starting at age 85-94.  By the tabled numbers (assuming 
dementia data are similar for men and women), 24.8% will have YCOGL<YHABL in the next 
10 years, leaving 75,200 with YCOGL >YHABL.  Of these, 68.943 would die in the 10 year 
period, meaning that YCOGL >YHABL for all of them.  Of the 6527 still alive, according to the 
table, 2302 would have YCOGL<YHABL, and 3954 would have YCOGL >YHABL.  Thus, the 
total of the original 100,000 who had YCOGL >YHABL throughout their remaining lives is 
68,943 + 3,954 = 72, 897, or about 73%.  Through increasingly tedious calculations, we 
estimated the % for whom YCOGL >YHABL throughout their remaining lives at younger ages.  
Table 8.2 shows that for about 63% to 74% of the persons, depending on initial age, YCOGL 
>YHABL.   
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Table 8.2 
Crude estimate of lifetime percentage with YCOGL >YHABL 
Age Women Men 
70 73 77 
80 74 77 
90 73 74 
100 63 63 
   
 
 
 
    
    
    
    
 
 These calculations required several strong assumptions.  First, we used age-specific 
mortality rates, but combined dementia data.  (Results were slightly better for men because they 
died sooner).  Second, we assumed that mortality and the onset of dementia were statistically 
independent.  Third, we assumed that the percentages in Table 8.1 were for a decade when they 
were really only for 9 years.  And finally, we assumed that a single decade where 
YCOGL<YHABL cancelled out any positive results in any other decade.  The results in Table 
8.2 clearly should not be over-interpreted, but they do justify the statement in the CHSHLC that 
YCOGL is usually greater than YHABL. 
Thus, based on these numbers, the great majority of older adults should have more 
lifetime YCOGL than lifetime YHABL.   This was true for 100-37 = 63% of persons starting at 
age 95, and that number will be higher for persons starting at younger ages. Therefore,  is 
reasonable to assume that  the years in which a person is both healthy and able will also be 
cognizant.   This is consistent with other research showing that cognition declines at a slower 
rate than do self-rated health and ADL abilities.  
 
2.  Using the observed and imputed longitudinal 3MSE and TICS data for 20-year 
cognition. 
 We used the 20-year longitudinal cognitive data to calculate YCOGL20, which is the 
number of years (in the 20 years after baseline) when the person had a 3MSE score (real, 
estimated from TICS or imputed) >80.  We then compared YCOGL20 to YHABL20.  For  75% 
of the CHS enrollees, YCOGL20  > YHABL20.    We take that to mean that YCOGL  > 
YHABL for most people, and that because of that, it is usually safe to use YHABL to plan for 
the future.   
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Appendix 9 
Could variables that were not included in the CHSHLC have improved the estimates? 
Introduction 
 The CHS Healthy Life Calculator (to be found at https://healthylifecalculator.org/) was created 
by scanning all of the appropriate baseline variables, and choosing the best predictors.  Clearly, there 
are many ways that “appropriate” and “best” could be defined.  Here are the restrictions we used: 
a. Only variables that could easily be answered by a person in a short questionnaire 
b. Only variables that were observed for 5800 or more CHS enrollees (98.5%) 
c. Only variables that were highly statistically significant (p<.0001 for stage 1, p<.01 for 
stage 2) for all eight of the outcomes:  YOL, YHL, YAL, YABL for men and for women. 
These exclusions thus removed from consideration all of the lab and physical exam results, as 
well as any scales that were calculated from lengthy questionnaires, or variables that performed 
differently for men and women.  Here is what happened when we relaxed some of those restrictions. 
Methods 
 We chose the additional variables to check for eclectic reasons, including whether early CHSHLC 
users had asked about them, whether they had been  used in Mini Jacob’s paper, whether they had 
been excluded from the original analysis as too hard to answer, or just for our own curiosity.  Variables 
that were binary were used as-is.  Variables with more than two categories were dichotomized to 
indicate approximately the “top third” of the distribution.  (The actual proportions are shown in Table 
9.0a and 9.0b.) 
 For each new variable, we ran 8 regressions, for 4 outcomes (YOL, YHL, YAL, YHABL) and both 
genders.  The dependent variable was the residual of the CHSHLC (observed minus estimated).  We 
computed a regression with no constant term, so that the regression coefficient would correspond to 
the adjustment to the predicted value that could be reasonable for this variable. 
 The regression coefficients (the increases) and their p-values are shown in Tables 9.1 – 9.3.  To 
aid in discussion, we highlighted coefficients > .5 years (6 months) and p-values < 0.01. 
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Results 
 
0.0 Descriptive statistics 
 
Tables 9.0a and 9.0b give descriptive statistics for all of the variables in this analysis, separate 
for women and for men.   The N is the number of known observations for each variable.   The first four 
variables are the dependent variables, and the remaining are the new variables that are examined here  
(all coded 0/1).  The mean of the binary variables can be interpreted as the proportion who have  that 
characteristic; i.e., 30.21% of the women were in the KCAL_high group (defined below).   
 
 
Table 9.0A  Female Descriptive Statistics 
 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
YOL_LIFE 3393 .25 28.87 15.2669 7.66468 
YHL_LIFE 3393 .00 26.11 9.7661 7.01442 
YAL_LIFE 3393 .00 27.01 10.7513 7.52845 
YHABL_LIFE 3393 .00 25.38 7.9309 6.79222 
KCAL_HIGH 3032 .00 1.00 .3021 .45925 
BLOCKS_HIGH 3393 .00 1.00 .0754 .26415 
healthyeating 3393 .00 1.00 .2756 .44687 
OBESEBASE 3393 .00 1.00 .2293 .42044 
chfbase 3393 .00 1.00 .0239 .15267 
anysubth 3393 .00 1.00 .6281 .48339 
depscr05 3386 .00 1.00 .4616 .49860 
diag01 3387 .00 1.00 .1411 .34820 
Lucid 3M > 90 3393 .00 1.00 .6110 .48760 
brach 3329 .00 1.00 .4533 .49789 
glu44 3337 .00 1.00 .2298 .42080 
black 3393 .00 1.00 .1712 .37677 
anyapoe4 3018 .00 1.00 .2545 .43564 
Valid N (listwise) 2632     
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Table 9.0B Male Descriptive Statistics 
 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
YOL_LIFE 2495 .25 27.52 12.1757 7.20514 
YHL_LIFE 2495 .00 25.21 8.3924 6.54287 
YAL_LIFE 2495 .00 25.79 9.4018 6.95087 
YHABL_LIFE 2495 .00 24.57 7.2349 6.32798 
KCAL_HIGH 2294 .00 1.00 .3766 .48465 
BLOCKS_HIGH 2495 .00 1.00 .1427 .34982 
healthyeating 2495 .00 1.00 .2593 .43835 
OBESEBASE 2495 .00 1.00 .1555 .36246 
chfbase 2495 .00 1.00 .0333 .17937 
anysubth 2495 .00 1.00 .7431 .43702 
depscr05 2492 .00 1.00 .3258 .46878 
diag01 2491 .00 1.00 .1453 .35250 
Lucid 3M > 90 2495 .00 1.00 .5603 .49645 
brach 2471 .00 1.00 .4379 .49623 
glu44 2471 .00 1.00 .2906 .45412 
black 2495 .00 1.00 .1375 .34442 
anyapoe4 2222 .00 1.00 .2516 .43402 
Valid N (listwise) 2007     
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1.0 Table 9.1 shows the results for 4 variables related to exercise and diet.  Exercise was already 
represented in the CHSHLC by “blocks walked” but some users did not think it gave enough credit for 
serious exercisers.  No dietary variables were screened or usedl 
 KCAL_high (from KCAL, total KCALS of physical activity) is a variable that indicates being in the 
top third of energy expenditure, and includes more activities than walking.  The first entry shows that 
the coefficient of YOL for men was 0.59 years, and the p-value was .002.  That is, a reasonable “fix” for a 
man who believed he was in the top tertile of energy expenditure would be to add .59 years (7 months) 
to the calculator estimate.  Values >.5 years or p<.01 are highlighted throughout.    Note that for men, 
the coefficient was always >.5 and the p-value was always less than .01, suggesting that a highly active 
man could probably justify adding about half a year to each of his calculator estimates.  There was no 
evidence that women needed any adjustment, because their coefficients were small and the p-values 
large.  The gender difference may be because in 1990 women mainly exercised by walking, and/or did 
not exercise as much as men. 
 Blocks_high is a binary variable that is 1 if the person walked more than 100 blocks per week 
(the calculator limit was 72 blocks), and 0 otherwise.  Although Blocks was already in the calculator, it 
was used on the log scale, so that there was a diminishing return on walking built into the model.  (The 
log scale was chosen to reduce the effect of outliers, and was also a slightly better predictor than blocks 
measured on the linear scale.)  Coefficients were not large, were actually negative for women,  and were 
never significantly different from zero.  No adjustment is indicated, for men or for women.   
 HEI_high refers to being in the top third of the healthy eating index.  This variable was not 
originally screened, because it was not available for cohort 2.  In Mini’s paper, HEI was significantly 
related to YAL/YOL% (% of remaining life that was Able).  Table 9.1 shows that HEI_high would be a good 
additional predictor only for YHL for women.  (Mini’s analysis controlled for potential confounders, while 
the CHSHLC controlled for the variables that were the best predictors.)   This could suggest adding half a 
year of YHL for women who “eat right”, but the inconsistency of the results suggests that this is likely to 
be a chance finding. 
 Obesity was not specifically considered in screening for the original calculator variables, 
although the BMI value was screened.  Here, we screened a specific indicator for obesity.   Table 9.1  
shows that obese persons might reasonably decrease  their  YAL and YHABL predictions by about half a 
year. 
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Table 9.1 
Exercise and Diet 
        
          
 
KCAL_HIGH YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.59 0.002 0.69 0.000 0.61 0.001 0.69 0.000 
 
F 0.00 0.982 0.02 0.902 0.11 0.557 0.06 0.717 
          
 
BLOCKS_HIGH YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.15 0.627 0.06 0.816 0.02 0.940 0.13 0.607 
 
F -0.54 0.139 -0.06 0.877 -0.53 0.131 -0.21 0.515 
          
 
HEI_HIGH (cohort 1) YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.21 0.363 0.29 0.149 0.18 0.402 0.21 0.269 
 
F 0.37 0.058 0.55 0.003 0.15 0.402 0.33 0.052 
          
 
OBESE YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.08 0.794 -0.28 0.284 -0.66 0.018 -0.55 0.026 
 
F -0.05 0.818 -0.34 0.104 -0.66 0.001 -0.60 0.001 
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2.0 The variables in Table 9.2 were originally either unscreened or were screened but failed. 
CHFbase was originally screened and did not enter then.  (Some other heart variables were 
included in the calculator).  In the current check, although the coefficients are quite large and the signs 
make sense for all outcomes, there was only a “significant” result for YOL.  The user who asked us about 
his CHF said that medication suppresses most of his symptoms, and so he had a fairly good prognosis for 
YHL and YAL based on the calculator.  Perhaps the results are due in part to the small number of CHS 
enrollees who had CHF at baseline (2% of women, 3% of men).  It might have been wise to include CHF 
with the other heart variables in the calculator, for completeness. 
ANYSUBTH (subclinical disease from the baseboth variables, not including echo) notes whether 
a person had any subclinical findings (about 70% did).  ANYSUBTH was not originally screened because 
the user would not have been able to answer this question.  In Table 9.2 ANYSUBTH is always a 
statistically significant predictor, but the coefficients (and the recommended amount of adjustment) 
would all be less than half a year. 
Depression (CESD scale) was not originally screened because it required a lengthy 
questionnaire.  The calculator did, however, include a rating of the user’s feeling about her life as a 
whole, from Terrible to Delighted, which was correlated with the CESD. Table 9.2 shows the results of 
being in the highest (worst) third of the responses.  The results are not very consistent, but  YHABL 
might reasonably be decreased by about half a year for people in the worst third of the depression 
scale. 
Diag01 is a history of previous cancer (currently being treated for cancer was an exclusion for 
CHS). Table 9.2 suggests that it may be reasonable to decrease scores for women (but not for men) by 
about 6 to 12 months.  The inconsistency of the findings by sex is unexplained.   
Lucid  indicates a baseline 3MSE of 90 or higher. We chose a high threshold to ensure that there 
were enough people in the lower group for this analysis.   Scores below 90 do not necessarily indicate 
dementia, especially since all CHS enrollees were lucid enough  to participate in the demanding baseline 
clinic visits. Lucid was significantly associated with YHL and YHABL, although the coefficient is only about 
3 months.  The result is consistent by sex, but does not hold as strongly for YOL or YAL. 
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Table 9.2 
Conditions not in the Calculator 
       
 
chfbase YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M -1.47 0.019 -0.58 0.306 -0.78 0.191 -0.40 0.456 
 
F -1.55 0.018 -0.53 0.403 -0.64 0.303 -0.03 0.962 
          
 
ANYSUBTH YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M -0.47 0.000 -0.39 0.001 -0.35 0.006 -0.30 0.009 
 
F -0.46 0.000 -0.40 0.001 -0.35 0.004 -0.35 0.002 
          
 
DEPRESSION SCORE YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.05 0.785 -0.37 0.040 -0.25 0.183 -0.46 0.006 
 
F -0.04 0.809 -0.46 0.001 -0.30 0.035 -0.50 0.000 
          
 
diag01 YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M -0.10 0.737 0.10 0.718 -0.12 0.680 0.12 0.625 
 
F -0.99 0.000 -0.65 0.013 -0.80 0.002 -0.55 0.021 
          
 
lucid 3MSE > 90 YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.27 0.073 0.36 0.008 0.30 0.037 0.35 0.007 
 
F 0.29 0.026 0.33 0.008 0.29 0.016 0.28 0.014 
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3.0  A few more variables 
 In Table 9.3, BRACH (average brachial pressure for AAI) was found to be one of the best 
predictor variables in this new analysis; it was originally excluded because it couldn’t be self-reported.  
Noting whether the person was in the top 45% of BRACH (coded from  a previous analysis) could have 
been a meaningful additional factor (coefficient was about 9 months for men, but not for women). 
 GLU44 (baseline glucose in about the top quarter) was a strong predictor which was not 
originally screened because people would not be able to self-report it.  Glucose was meaningful here, 
even though self-reported diabetes was already in the calculator.  Perhaps GLU44 reflects untreated 
diabetes.  There were consistent results for men and women, although YHL was not as strongly 
statistically significant for women.  A decrease of 9 months for all outcomes would be reasonable. 
 Black Race was originally screened and did not enter.  Just to be sure, I looked at it again.  There 
is no evidence that the CHSHLC requires adjustment for black persons, except YHABL for men only.  
 APOE  allele 4.  This variable represents “any allele 4”, and combines APOE categories 3 (2,4), 5 
(3,4) and 6 (4,4).   It is the genetic variable measured on the most CHS enrollees.   The significance level 
was never <.01, and the coefficients were only on the order of 3 months.   This genetic variable would 
not have made any difference to the calculations. 
 
Table 9.3 
Other variables 
        
 
BRACH YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M -0.75 0.000 -0.80 0.000 -0.73 0.000 -0.73 0.000 
 
F -0.37 0.014 -0.32 0.030 -0.38 0.008 -0.33 0.015 
          
 
glu44 YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M -0.77 0.000 -0.80 0.000 -0.74 0.000 -0.77 0.000 
 
F -0.55 0.010 -0.54 0.009 -0.53 0.009 -0.44 0.018 
          
 
BLACK YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M -0.06 0.857 -0.43 0.132 0.04 0.892 0.59 0.018 
 
F -0.11 0.640 -0.24 0.309 -0.43 0.051 -0.03 0.962 
          
 
APOE 4 YOL 
 
YHL 
 
YAL 
 
YHABL 
 
 
M 0.32 0.023 0.28 0.024 0.30 0.021 0.26 0.026 
 
F 0.22 0.071 0.22 0.064 0.24 0.038 0.19 0.085 
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Conclusions 
Many CHS variables were excluded from the CHS Healthy Life Calculator because of the 
selection requirements listed  in the introduction to this appendix.  We examined whether a selection of 
additional variables could have made a meaningful and significant improvement to the CHSHLC.   
Most of the variables checked would not have contributed in a meaningful way to the Healthy 
Life Calculator, which is an encouraging finding for the calculator.  Based on this analysis, it might have 
been reasonable to adjust the calculator results for  KCAL, Obesity, ANYSUBTH, Brach, and Glu44, if 
there were any easy way for people to self-report these variables .  Their coefficients were meaningful 
(>.5 years) and statistically significant (p<.01), though not always for both sexes.   It isn’t clear, however, 
how we could have included them in a user-friendly way.   
 Some preliminary work (not shown) found that the R2 values for prediction were not much 
higher when the larger set of variables (including those not previously allowed) was screened.  There 
seems to be a natural limit of about 0.4 in the R2.   This would suggest that adding more variables would 
not make a meaningful change in the variance of the prediction. 
Three of the four outcomes (all but YOL) were based on self-ratings of health or function.  
Perhaps that explains why the new, non-self-rated variables did not add much to the predictions. 
 In nearly all cases, the new variables checked would not have improved the calculator.  This 
suggests that the methods used to choose predictor variable were acceptable. 
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